Diabetes Prevention: Near-Complete Reversal in Prediabetes The SURMOUNT-1 extension trial followed patients with prediabetes and obesity on tirzepatide for 176 weeks
These drugs essentially mimic going on a diet, influencing ones portion control and how often they eat
At present, semaglutide stands out as the sole GLP-1 RA approved for lowering the risks associated with worsening kidney disease, kidney failure, and CVD-related mortality in adults with T2D and CKD [76]
"Many patients do very well on injectable therapies, but there are some inconveniences with long-term injections, such as travel, storage requirements, injection fatigue, or personal preference," Betul Hatipoglu, MD, a professor of medicine at Case Western Reserve University and endocrinologist at University Hospitals Cleveland, told Verywell in an email
It helps in developing new methodologies in peptide science